Narcolepsy can lead to excessive daytime sleepiness, as well as cataplexy, a sudden loss of muscle tone. Other symptoms can include sleep paralysis and hallucinations that occur both during sleep ...

Millions of Americans suffer from sleep disorders that can lead to serious health issues, including heart disease, diabetes ...

Catching up on sleep over weekends may be an easy way for teens to support their mental health.

Internal circadian rhythms influence immune biomarkers and may affect bacterial infection risk, beyond genetics or environment.

Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

Alkermes wins FDA Breakthrough Therapy status for alixorexton in NT1 after Vibrance-1 data shows improvement in wakefulness.

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

In obstructive sleep apnea, using CPAP therapy more than 4 hours a night sharply cuts residual sleepiness and lowers crash ...

A major new study has found a notable connection between untreated sleep apnea and an increased risk of Parkinson’s disease. A team of researchers from Oregon Health and Science University (OHSU) ...

A new study found people with untreated obstructive sleep apnea could have an increased risk of developing Parkinson’s disease. Researchers studied medical records for more than 11 million military ...

Alkermes plc (NASDAQ:ALKS) released topline results on Wednesday from the Vibrance-2 dose-ranging phase 2 study evaluating alixorexton (formerly ALKS 2680) in narcolepsy type 2 (NT2). Narcolepsy type ...

Background: Periodic limb movement disorder (PLMD) is a sleep-related movement disorder, which may be accompanied by a complaint of excessive daytime sleepiness (EDS). With this study, we reported a ...